Cambridge, Massachusetts– Medical sensors are infamous for being bulky and not mobile-friendly. But they are also known for their extreme accuracy and lifesaving capabilities. Embrace is a medical watch that you won’t be ashamed to wear out in public. It is strategically designed to be a fashionable way of reducing stress for those suffering with epilepsy and for caregivers who are constantly monitoring their loved ones that struggle with epilepsy daily.

Epilepsy affects over 50 million people worldwide and 30% of those diagnosed are children.

Embrace is not just another step counter that conveniently rests on your wrist. And it’s not a wearable that you are likely to throw into a drawer to collect dust after it is given to you as a gift this holiday season. After many years of research at MIT labs, Embrace has surfaced and was recently crowd-funded on Indiegogo to raise funds for further development. Embrace has already been regarded as a next-level fitness tracker that is designed to save lives.

Embrace is able to alert caregivers when unusual events like a convulsive seizure occur. But it’s not just for people struggling to manage their epilepsy symptoms. Embrace is being marketed to anyone that wants to find out more about their stress levels, physical activity, or even monitor their sleeping patterns.

And did I mention that the first 4,000 backers get to put one of these life-saving devices into the hands of children before December 25th?

 


About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.